Skip to content
    Johnson & Johnson Innovation logo

    Johnson & Johnson Innovation

    New Brunswick, New Jersey, United StatesFounded 1973
    jnjinnovation.comLinkedIn
    Biotech & Life SciencesHealthcare

    Johnson & Johnson Innovation – JJDC, Inc. is the strategic corporate venture capital arm of Johnson & Johnson, making equity investments in transformative healthcare and technology companies. Founded in 1973, it invests across all stages from seed to late-stage, focusing on pharmaceuticals, medical devices, and consumer health.

    37% of their portfolio is in Biotech & Life Sciences. Average disclosed round size is $67.0M (across 50 rounds with reported amounts).

    Find people at Johnson & Johnson Innovation on Goldilocks AI

    Portfolio

    45

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    3

    Team

    BI

    Brian Imszennik

    Director, Venture Investments at Johnson & Johnson

    RS

    Robert Sohn

    Sr. Director at Johnson & Johnson Innovation - JJDC

    AB

    Amir Blatt

    Principal, Venture Investments

    TM

    Tamir Meiri

    Investment

    AX

    Asish Xavier

    Johnson & Johnson Innovation - JJDC

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    63 investments
    CompanyRoundAmountDate
    TECLens, Inc. logoTECLens, Inc.Unknown$10MAug 2026
    Fesarius Therapeutics logoFesarius TherapeuticsSeries A$20MJun 2026
    Ronovo Surgical logoRonovo SurgicalSeries D$67MSep 2025
    TRIMTECH Therapeutics logoTRIMTECH TherapeuticsSeed$14MMar 2025
    Ronovo Surgical logoRonovo SurgicalSeries C—Jan 2025
    Prazer Therapeutics logoPrazer TherapeuticsSeries B$20MJan 2025
    TECLens, Inc. logoTECLens, Inc.Series A$9.3MJan 2025
    Citryll logoCitryllSeries B—Dec 2024
    SpectraWAVE logoSpectraWAVESeries B$50MSep 2024
    Prana Thoracic, Inc. logoPrana Thoracic, Inc.Series A$3MAug 2024
    Osteal Therapeutics, Inc. logoOsteal Therapeutics, Inc.Unknown$50MJun 2024
    FFlindr Therapeutics B.V.Series A—Apr 2024
    GGRAIL, Inc.Series B$900MMar 2024
    ONL Therapeutics logoONL TherapeuticsUnknown$65MJan 2024
    Ronovo Surgical logoRonovo SurgicalSeries B$44MJan 2024
    LLoci OrthopaedicsSeries A—Jan 2024
    Osteal Therapeutics, Inc. logoOsteal Therapeutics, Inc.Series C$23MSep 2023
    Astraveus logoAstraveusSeed—Jun 2023
    Astraveus logoAstraveusSeed—Jan 2023
    Prana Thoracic, Inc. logoPrana Thoracic, Inc.Series A$3MJan 2023
    Rapport logoRapportSeries A$100MJan 2023
    RefleXion Medical logoRefleXion MedicalSeries C$100MJan 2023
    RefleXion logoRefleXionSeries C$105MJan 2023
    Medcrypt logoMedcryptSeries B$25MNov 2022
    Osteal Therapeutics, Inc. logoOsteal Therapeutics, Inc.Series B$30MMar 2022
    Page 1 of 3

    Top Co-Investors

    Sofinnova Partners8 shared
    Pfizer Ventures8 shared
    GV6 shared
    Breyer Capital5 shared
    T. Rowe Price5 shared
    ARCH Venture Partners5 shared
    Casdin Capital4 shared
    Novartis Venture Fund4 shared
    Dolby Family Ventures4 shared
    Eli Lilly and Company4 shared
    Venrock4 shared
    Ally Bridge Group4 shared
    Novo Capital4 shared
    Merck Global Health Innovation Fund3 shared
    THVC3 shared
    Forbion3 shared
    Eniac Ventures3 shared
    Intuitive Ventures3 shared
    Anzu Partners3 shared
    KCK Group3 shared

    Last updated: 7 October 2026